| Literature DB >> 25714200 |
Fernando A Atik1, Isaac Azevedo Silva1, Claudio Ribeiro da Cunha1.
Abstract
OBJECTIVE: To determine the prevalence and profile of ascending aorta or aortic arch atheromatous disease in cardiovascular surgery patients, its risk factors and its prognostic implication early after surgery.Entities:
Mesh:
Year: 2014 PMID: 25714200 PMCID: PMC4408809 DOI: 10.5935/1678-9741.20140058
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
Preoperative characteristics of patients with and without atheromatous aorta who underwent cardiovascular surgery.
| Atheromatosis | Control | ||
|---|---|---|---|
| (N=68) | (N=1974) | ||
| Age (years) | 65.8±9.7 | 54.3±15 | <0.0001 |
| Male | 45 (66.2%) | 1123 (56.9%) | 0.12 |
| Weight (kg) | 70.1±12.8 | 68.2±14.2 | 0.31 |
| Height (cm) | 164±10 | 170±27 | 0.87 |
| Previous cardiac surgery | 2 (2.9%) | 219 (11.1%) | 0.03 |
| I | 48 (70.6%) | 1015 (51.6%) | |
| II | 13 (19.1%) | 570 (29%) | 0.03 |
| III | 6 (8.8%) | 327 (16.6%) | |
| IV | 1 (1.5%) | 56 (2.8%) | |
| Coronary artery disease | 59 (86.8%) | 1103 (55.9%) | <0.001 |
| Acute coronary syndrome | 16 (23.5%) | 371 (18.8%) | 0.34 |
| Myocardial infarction <30d | 9 (13.2%) | 253 (12.8%) | 0.92 |
| Trunk lesion LC | 17 (25%) | 200 (10.1%) | <0.0001 |
| 1 | 3 (4.4%) | 96 (4.9%) | |
| 2 | 16 (23.5%) | 208 (10.5%) | 0.08 |
| 3 | 40 (58.8%) | 799 (40.5%) | |
| LV ejection fraction | 57.7±11.7 | 58.8±13.2 | 0.53 |
| Pulmonary hypertension | 0 | 157 (8%) | 0.01 |
| Carotid disease | 3 (4.4%) | 34 (1.7%) | 0.1 |
| Arterial hypertension | 59 (86.8%) | 1185 (60.2%) | <0.0001 |
| Diabetes mellitus | 26 (38.2%) | 460 (23.4%) | 0.004 |
| Dyslipidemia | 33 (48.5%) | 675 (34.3%) | 0.01 |
| Smoking | 11 (16.2%) | 145 (7.4%) | 0.007 |
| Prior stroke | 5 (7.3%) | 103 (5.2%) | 0.44 |
| Atrial fibrillation | 2 (2.9%) | 226 (11.5%) | 0.02 |
| Peripheral vascular disease | 4 (5.9%) | 25 (1.3%) | 0.001 |
| Endocarditis | 0 | 58 (2.9%) | 0.15 |
| Creatinine | 1.09±0.9 | 1.3±1 | 0.08 |
| Serum hemoglobin | 13.3±1.8 | 13.5±1.9 | 0.52 |
Multivariate analysis of risk factors for atheromatous aorta in patients undergoing cardiovascular surgery.
| Variable | Estimate±SE | OR | CI 95% | |
|---|---|---|---|---|
| Atheromatosis | ||||
| Intercept | 3,24±0,33 | <0,0001 | ||
| Age > 61 years | 2,79 | 2,43 - 3,15 | ||
| 0,51±0,13 | <0,0001 | |||
| 3,1 | 2,8 - 3,44 | |||
| DAC | 0,57±0,19 | 0,002 | ||
| 2,26 | 1,82 - 2,7 | |||
| SAH | 0,41±0,19 | 0,03 | ||
| 3,15 | 2,83 - 3,46 | |||
| Peripheral vascular disease | 0,57±0,28 | 0,04 |
Hosmer-Lemeshow test, P=0.09; C-statistic 0.77, CAD=coronary artery disease, Hypertension. CAD=coronary artery disease; SH=systemic arterial hypertension
Morbidity and mortality data in patients with and without aortic atheromatosis undergoing cardiovascular surgery.
| Atheromatosis | Control | ||
|---|---|---|---|
| (N=68) | (N=1974) | ||
| Hospital mortality | 12 (17.6%) | 114 (5.7%) | <0.0001 |
| Stroke | 7 (10.4%) | 44 (2.2%) | <0.0001 |
| Myocardial infarction | 10 (14.7%) | 96 (4.8%) | 0.0003 |
| Sepsis | 13 (19.1%) | 136 (6.9%) | 0.0001 |
| Acute renal failure | 12 (17.6%) | 81 (4.1%) | <0.0001 |
| Prolonged mechanical ventilation | 6 (8.9%) | 44 (2.2%) | 0.0005 |
| Intensive care unit stay (days) | 3 (2; 5) | 2 (2; 4) | 0.24 |
| Length of stay (days) | 15 (8; 25) | 11 (7; 19) | 0.03 |
Multivariate analysis of the occurrence of stroke in patients undergoing cardiovascular surgery.
| Variable | Estimate±SE | OR | CI 95% | |
|---|---|---|---|---|
| Atheromatosis | ||||
| Intercept | -0.31±0.65 | 0.64 | ||
| 3.46 | 3.18 - 3.76 | |||
| Atheromatosis | 0.62±0.24 | 0.01 | ||
| 9.42 | 1.98 - 42.6 | |||
| Ejection fraction | 2.84±0.99 | 0.004 | ||
| 3.86 | 1.93 - 5.35 | |||
| Functional class IV | 1.35±0.4 | 0.0007 |
Hosmer-Lemeshow test, P=0.9; C-statistic 0.7
| Abbreviations, acronyms and symbols | |
|---|---|
| CABG | Coronary artery bypass grafting |
| LC | Left coronary |
| LV | Left ventricle |
| NYHA | New York Heart Association |
| Authors' roles & responsibilities | |
|---|---|
| FAA | Data collection, statistical analysis, data interpretation and writing of the manuscript |
| IAS | Manuscript writing |
| CRC | Manuscript review |